Differentiation of residual tumor from benign peri-ablational tissues after radiofrequency ablation: The role of MR imaging contrast agents [3] (multiple letters)

Radiology

Volumn 237, Issue 2, 2005, Pages 745-749

  Ni, Yicheng ^a   Chen, Feng ^a   Marchal, Guy ^a   Kim, Tae Jung ^b   Moon, Woo Kyung ^b   Goldberg, S Nahum ^c  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Seoul National University Hospital   (South Korea)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE MEGLUMINE; SHL 643A; UNCLASSIFIED DRUG;

BENIGN TUMOR; CAPILLARY FLOW; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DRUG DISTRIBUTION; IMAGE ENHANCEMENT; LETTER; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; RADIOFREQUENCY ABLATION; STANDARDIZATION;

ANIMALS; CATHETER ABLATION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; GADOLINIUM; GADOLINIUM DTPA; HEAT; MAGNETIC RESONANCE IMAGING; NEOPLASM, RESIDUAL; NEOPLASMS, EXPERIMENTAL; RABBITS;

EID: 22844440759     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2372050400     Document Type: Letter

References (0)